Attenuated Psychosis Syndromes Among Mexican Youth and Young Adults: A Culturally Relevant Case Illustration Approach

  • Francisco Reyes-Madrigal
  • Pablo León-Ortiz
  • Camilo de la Fuente-SandovalEmail author


The concept of an attenuated psychosis syndromes has focused attention on early intervention to prevent or attenuate full-blown psychosis. This work is becoming increasingly internationalized, which warrants special consideration of cultural differences in conceptualization of mental illness and international differences in healthcare practices and rights regarding research participation. However, in Mexico, there is a scarcity of resources for mental healthcare, especially for psychosis spectrum disorders, and many clinicians are not very familiar with attenuated psychosis syndromes. Moreover, current studies have not allowed for an in-depth examination of the challenges and the strategies of working with youth from the range of specific cultures. The purpose of this chapter was to critically review in Mexico the health system, stigma, cultural values, and beliefs about mental illness (psychosis in particular) and how these may make adaptations to interventions necessary while highlighting specific challenges that Mexican populations encounter. We also present the implemented methodology in a local evaluation program and describe country-specific literature. Finally, we provide a clinical vignette to illustrate these challenges and the relevance of cultural aspects in clinical practice, highlighting the challenges of identifying and treating Mexican youth at risk for psychosis and their families.


  1. Abdullah, T., & Brown, T. L. (2011). Mental illness stigma and ethnocultural beliefs, values, and norms: An integrative review. Clinical Psychology Review, 31(6), 934–948.PubMedCrossRefGoogle Scholar
  2. Addington, J., Cadenhead, K. S., Cannon, T. D., Cornblatt, B., McGlashan, T. H., Perkins, D. O., … North American Prodrome Longitudinal, S. (2007). North American Prodrome Longitudinal Study: A collaborative multisite approach to prodromal schizophrenia research. Schizophrenia Bulletin, 33(3), 665–672.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Andrés-Hyman, R. C., Ortiz, J., Añez, L. M., & Davidson, L. (2006). Culture and clinical practice: Recommendations for working with Puerto Ricans and other Latinas(os) in the United States. Professional Psychology: Research and Practice, 37(6), 694–701.CrossRefGoogle Scholar
  4. APAL, & APM. (2014). Consenso Nacional y Guía de Práctica Clínica de la Asociación Psiquiátrica Mexicana y de la Asociación Psiquiátrica de América Latina para el tratamiento de las personas con esquizofrenia. Salud Mental, 37(Suplemento 1), 7–118.Google Scholar
  5. Berenzon, S., & Juarez, F. (2005). Mental health services to poor patients with affective disorders in Mexico City. Revista de Saúde Pública, 39(4), 619–626.PubMedCrossRefGoogle Scholar
  6. Berenzon-Gorn, S., Ito-Sugiyama, E., & Vargas-Guadarrama, L. A. (2006). Diseases and illnesses for which help is sought from traditional healers in Mexico City. Salud Publica de Mexico, 48(1), 45–56.PubMedCrossRefGoogle Scholar
  7. Berenzon-Gorn, S., Saavedra-Solano, N., & Alanís-Navarro, S. (2009). Estrategias utilizadas por un grupo de mujeres mexicanas para cuidar su salud emocional: autoatención y apoyo social. Salud Publica de Mexico, 51(6), 7.CrossRefGoogle Scholar
  8. Borges, G., Medina-Mora, M. E., Wang, P. S., Lara, C., Berglund, P., & Walters, E. (2006). Treatment and adequacy of treatment of mental disorders among respondents to the Mexico National Comorbidity Survey. American Journal of Psychiatry, 163(8), 1371–1378.PubMedCrossRefGoogle Scholar
  9. Cannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., … Heinssen, R. (2008). Prediction of psychosis in youth at high clinical risk: A multisite longitudinal study in North America. Archives of General Psychiatry, 65(1), 28–37.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Cloninger, C. R. (2008). The psychobiological theory of temperament and character: Comment on Farmer and Goldberg (2008). Psychological Assessment, 20(3), 292–299; discussion 300–294.PubMedCrossRefGoogle Scholar
  11. Corcoran, R., Cummins, S., Rowse, G., Moore, R., Blackwood, N., & Howard, R. (2006). Reasoning under uncertainty: Heuristic judgments in patients with persecutory delusions or depression. Psychological Medicine, 36(8), 1109–1118.PubMedCrossRefGoogle Scholar
  12. de la Fuente-Sandoval, C., Leon-Ortiz, P., Azcarraga, M., Favila, R., Stephano, S., & Graff-Guerrero, A. (2013). Striatal glutamate and the conversion to psychosis: A prospective 1H-MRS imaging study. International Journal of Neuropsychopharmacology, 16(2), 471–475.PubMedCrossRefGoogle Scholar
  13. de la Fuente-Sandoval, C., Leon-Ortiz, P., Favila, R., Stephano, S., Mamo, D., Ramirez-Bermudez, J., & Graff-Guerrero, A. (2011). Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis. Neuropsychopharmacology, 36(9), 1781–1791.PubMedPubMedCentralCrossRefGoogle Scholar
  14. de la Fuente-Sandoval, C., Reyes-Madrigal, F., Mao, X., Leon-Ortiz, P., Rodriguez-Mayoral, O., Solis-Vivanco, R., … Shungu, D. C. (2015). Cortico-striatal GABAergic and glutamatergic dysregulations in subjects at ultra-high risk for psychosis investigated with proton magnetic resonance spectroscopy. International Journal of Neuropsychopharmacology, 19(3), pyv105.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Espinola-Nadurille, M., Vargas Huicochea, I., Raviola, G., Ramirez-Bermudez, J., & Kutcher, S. (2010). Mental health care reforms in Latin America: Child and adolescent mental health services in Mexico. Psychiatric Services, 61(5), 443–445.PubMedCrossRefGoogle Scholar
  16. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2002). Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. New York, NY: Biometrics Research, New York State Psychiatric Institute.Google Scholar
  17. Flores-Reynoso, S., Medina-Dávalos, R., & Robles-García, R. (2011). Estudio de traducción al español y evaluación psicométrica de una escala para medir el estigma internalizado en pacientes con trastornos mentales graves. Salud Mental, 34(4), 333–339.Google Scholar
  18. Flores-Reynoso, S., Medina-Dávalos, R., Robles-García, R., & Páez-Agraz, F. (2012). Estigma y apego al tratamiento psiquiátrico en los trastornos mentales severos y persistentes. Revista Latinoamericana de Psiquiatría, 11(3), 82–89.Google Scholar
  19. Frenk, J. (2006). Bridging the divide: Global lessons from evidence-based health policy in Mexico. Lancet, 368(9539), 954–961.PubMedCrossRefGoogle Scholar
  20. Fresan, A., Leon-Ortiz, P., Robles-Garcia, R., Azcarraga, M., Guizar, D., Reyes-Madrigal, F., … de la Fuente-Sandoval, C. (2015). Personality features in ultra-high risk for psychosis: A comparative study with schizophrenia and control subjects using the Temperament and Character Inventory-Revised (TCI-R). Journal of Psychiatric Research, 61, 168–173.PubMedCrossRefGoogle Scholar
  21. Fresan, A., Robles-Garcia, R., de Benito, L., Saracco, R., & Escamilla, R. (2010). Development and psychometric properties of a brief instrument to measure the stigma of aggressiveness in schizophrenia. Actas Españolas de Psiquiatría, 38(6), 340–344.PubMedGoogle Scholar
  22. Fresan, A., Robles-Garcia, R., Lopez-Avila, A., & Cloninger, C. R. (2011). Personality differences according to age and sex in a Mexican sample using the Temperament and Character Inventory-Revised. Comprehensive Psychiatry, 52(6), 774–779.PubMedCrossRefGoogle Scholar
  23. Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rossler, A., Schultze-Lutter, F., … Yung, A. (2013). The psychosis high-risk state: A comprehensive state-of-the-art review. JAMA Psychiatry, 70(1), 107–120.PubMedPubMedCentralCrossRefGoogle Scholar
  24. Galli, E., Heinze, G., Escalante, C. A., Fernández-Labriola, R., León, C., Moreno, R. A., … Vengoechea, J. (2000). Encuesta Latinoamericana sobre la Actitud de los Profesionales de la Salud hacia la Prescripción de los Psicofármacos. Estudio comparativo con la Realidad Peruana. Revista Médica Herediana, 11(3), 79–88.CrossRefGoogle Scholar
  25. Gater, R., de Almeida e Sousa, B., Barrientos, G., Caraveo, J., Chandrashekar, C. R., Dhadphale, M., et al. (1991). The pathways to psychiatric care: A cross-cultural study. Psychological Medicine, 21(3), 761–774.PubMedCrossRefGoogle Scholar
  26. Gomez-Dantes, O., Sesma, S., Becerril, V. M., Knaul, F. M., Arreola, H., & Frenk, J. (2011). The health system of Mexico. Salud Publica de Mexico, 53(Suppl 2), s220–s232.PubMedGoogle Scholar
  27. Hogan, T. P., Awad, A. G., & Eastwood, R. (1983). A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychological Medicine, 13(1), 177–183.PubMedCrossRefGoogle Scholar
  28. Hori, H., Noguchi, H., Hashimoto, R., Nakabayashi, T., Saitoh, O., Murray, R. M., … Kunugi, H. (2008). Personality in schizophrenia assessed with the Temperament and Character Inventory (TCI). Psychiatry Research, 160(2), 175–183.PubMedCrossRefGoogle Scholar
  29. INEGI. (2016). Indicadores de demografía y población – Instituto Nacional de Estadística y Geografía (INEGI). 2016, from
  30. INNN. (2016). El Instituto – Secretaría de Salud, Mexico. From
  31. Interian, A., Martinez, I. E., Guarnaccia, P. J., Vega, W. A., & Escobar, J. I. (2007). A qualitative analysis of the perception of stigma among Latinos receiving antidepressants. Psychiatric Services, 58(12), 1591–1594.PubMedCrossRefGoogle Scholar
  32. Jackson, C., & Birchwood, M. (1996). Early intervention in psychosis: Opportunities for secondary prevention. British Journal of Clinical Psychology, 35(Pt 4), 487–502.PubMedCrossRefGoogle Scholar
  33. Kegeles, L. S., Mao, X., Stanford, A. D., Girgis, R., Ojeil, N., Xu, X., … Shungu, D. C. (2012). Elevated prefrontal cortex gamma-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Archives of Genenral Psychiatry, 69(5), 449–459.CrossRefGoogle Scholar
  34. King, M., Dinos, S., Shaw, J., Watson, R., Stevens, S., Passetti, F., … Serfaty, M. (2007). The stigma scale: Development of a standardised measure of the stigma of mental illness. British Journal of Psychiatry, 190, 248–254.PubMedCrossRefGoogle Scholar
  35. Kingdon, D. G., & Turkington, D. (1991). The use of cognitive behavior therapy with a normalizing rationale in schizophrenia. Preliminary report. Journal of Nervous and Mental Disease, 179(4), 207–211.PubMedCrossRefGoogle Scholar
  36. Kovess-Masfety, V., Evans-Lacko, S., Williams, D., Andrade, L. H., Benjet, C., Ten Have, M., … Gureje, O. (2017). The role of religious advisors in mental health care in the World Mental Health surveys. Social Psychiatry and Psychiatric Epidemiology, 52(3), 353–367.PubMedCrossRefGoogle Scholar
  37. Lee, S. Y., Kim, K. R., Park, J. Y., Park, J. S., Kim, B., Kang, J. I., … Kwon, J. S. (2011). Coping strategies and their relationship to psychopathologies in people at ultra high-risk for psychosis and with schizophrenia. The Journal of Nervous and Mental Disease, 199(2), 106–110.PubMedCrossRefGoogle Scholar
  38. Lindenmayer, J. P., Liu-Seifert, H., Kulkarni, P. M., Kinon, B. J., Stauffer, V., Edwards, S. E., … Volavka, J. (2009). Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. Journal of Clinical Psychiatry, 70(7), 990–996.PubMedCrossRefGoogle Scholar
  39. Link, B. G., & Phelan, J. (1995). Social conditions as fundamental causes of disease. Journal Health and Social Behave, Spec No, 80–94.
  40. Link, B. G., & Phelan, J. C. (2006). Stigma and its public health implications. Lancet, 367(9509), 528–529.PubMedCrossRefGoogle Scholar
  41. Link, B. G., Struening, E. L., Neese-Todd, S., Asmussen, S., & Phelan, J. C. (2001). Stigma as a barrier to recovery: The consequences of stigma for the self-esteem of people with mental illnesses. Psychiatric Services, 52(12), 1621–1626.PubMedCrossRefGoogle Scholar
  42. Lozano, R., Gomez-Dantes, H., Garrido-Latorre, F., Jimenez-Corona, A., Campuzano-Rincon, J. C., Franco-Marina, F., … Murray, C. J. (2013). Burden of disease, injuries, risk factors and challenges for the health system in Mexico. Salud Publicade Mexico, 55(6), 580–594.CrossRefGoogle Scholar
  43. McGlashan, T. H., Addington, J., Cannon, T., Heinimaa, M., McGorry, P., O’Brien, M., … Yung, A. (2007). Recruitment and treatment practices for help-seeking “prodromal” patients. Schizophrenia Bulletin, 33(3), 715–726.PubMedPubMedCentralCrossRefGoogle Scholar
  44. Medina-Mora, M., Borges, G., Lara-Muñoz, C., Benjet, C., Blanco-Jaimes, J., Fleiz-Bautista, C., … Aguilar-Gaxiola, S. (2003). Prevalencia de Trastornos Mentales y Uso de Servicios: Resultados de la Encuesta Nacional de Epidemiología Psiquiátrica en México. Salud Mental, 26(4), 16.Google Scholar
  45. Miller, T. J., McGlashan, T. H., Rosen, J. L., Cadenhead, K., Cannon, T., Ventura, J., … Woods, S. W. (2003). Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: Predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin, 29(4), 703–715.PubMedPubMedCentralCrossRefGoogle Scholar
  46. Mondragon-Maya, A., Solis-Vivanco, R., Leon-Ortiz, P., Rodriguez-Agudelo, Y., Yanez-Tellez, G., Bernal-Hernandez, J., … de la Fuente-Sandoval, C. (2013). Reduced P3a amplitudes in antipsychotic naive first-episode psychosis patients and individuals at clinical high-risk for psychosis. Journal of Psychiatric Research, 47(6), 755–761.PubMedCrossRefGoogle Scholar
  47. Mora-Rios, J., Ortega-Ortega, M., & Natera, G. (2016). Subjective experience and resources for coping with stigma in people with a diagnosis of schizophrenia: An intersectional approach. Qualitative Health Research, 26(5), 697–711.PubMedCrossRefGoogle Scholar
  48. Nicolini, H. (2009). Study of the first psychotic episode and its prodromic phases in Mexico. Gaceta Médica de México, 145(2), 79–80.PubMedGoogle Scholar
  49. Novick, D., Haro, J. M., Suarez, D., Perez, V., Dittmann, R. W., & Haddad, P. M. (2010). Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Research, 176(2–3), 109–113.PubMedCrossRefGoogle Scholar
  50. OECD (2015), Health at a Glance 2015: OECD Indicators, OECD Publishing, Paris.
  51. Olfson, M., Marcus, S. C., Tedeschi, M., & Wan, G. J. (2006). Continuity of antidepressant treatment for adults with depression in the United States. American Journal of Psychiatry, 163(1), 101–108.PubMedCrossRefGoogle Scholar
  52. Olney, J. W., Newcomer, J. W., & Farber, N. B. (1999). NMDA receptor hypofunction model of schizophrenia. Journal of Psychiatric Research, 33(6), 523–533.PubMedCrossRefGoogle Scholar
  53. Pescosolido, B. A., Monahan, J., Link, B. G., Stueve, A., & Kikuzawa, S. (1999). The public’s view of the competence, dangerousness, and need for legal coercion of persons with mental health problems. American Journal of Public Health, 89(9), 1339–1345.PubMedPubMedCentralCrossRefGoogle Scholar
  54. Plitman, E., de la Fuente-Sandoval, C., Reyes-Madrigal, F., Chavez, S., Gomez-Cruz, G., Leon-Ortiz, P., & Graff-Guerrero, A. (2016a). Elevated myo-inositol, choline, and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: A proton magnetic resonance spectroscopy study with implications for glial dysfunction. Schizophrenia Bulletin, 42(2), 415–424.PubMedCrossRefGoogle Scholar
  55. Plitman, E., Nakajima, S., de la Fuente-Sandoval, C., Gerretsen, P., Chakravarty, M. M., Kobylianskii, J., … Graff-Guerrero, A. (2014). Glutamate-mediated excitotoxicity in schizophrenia: A review. European Neuropsychopharmacology, 24(10), 1591–1605.PubMedPubMedCentralCrossRefGoogle Scholar
  56. Plitman, E., Patel, R., Chung, J. K., Pipitone, J., Chavez, S., Reyes-Madrigal, F., … Graff-Guerrero, A. (2016b). Glutamatergic metabolites, volume and cortical thickness in antipsychotic-naive patients with first-episode psychosis: Implications for excitotoxicity. Neuropsychopharmacology. Scholar
  57. Ponce-De Leon, M. E., Varela-Ruiz, M., Marin-Campos, Y., Lifschitz, A., Sanchez-Mendiola, M., & Campillo, C. (2004). New tendencies in teaching medicine. Learning strategy in medicine. Gaceda Medica de Mexico, 140(3), 305–319.Google Scholar
  58. Ramirez-Bermudez, J. (2008). Protocolo de atención para el paciente con trastorno neuropsiquiátrico. 2016, from
  59. Ramirez-Bermudez, J., Soto-Hernandez, J. L., Lopez-Gomez, M., Mendoza-Silva, M., Colin-Piana, R., & Campillo-Serrano, C. (2005). Frequency of neuropsychiatric signs and symptoms in patients with viral encephalitis. Revista de Neurologia, 41(3), 140–144.PubMedCrossRefGoogle Scholar
  60. Read, J., Haslam, N., & Davies, E. (2009). The need to rely on evidence not ideology in stigma research. Acta Psychiatrica Scandinavica, 119(5), 412–413; author reply 413.PubMedCrossRefGoogle Scholar
  61. Robles Garcia, R., Salazar Alvarado, V., Paez Agraz, F., & Ramirez Barreto, F. (2004). Assessment of drug attitudes in patients with schizophrenia: Psychometric properties of the DAI Spanish version. Actas Españolas de Psiquiatría, 32(3), 138–142.PubMedGoogle Scholar
  62. Robles-Garcia, R., Fresan, A., Berlanga, C., & Martinez, N. (2013). Mental illness recognition and beliefs about adequate treatment of a patient with schizophrenia: Association with gender and perception of aggressiveness-dangerousness in a community sample of Mexico City. International Journal of Social Psychiatry, 59(8), 811–818.PubMedCrossRefGoogle Scholar
  63. Salgado-de Snyder, V. N., Diaz-Perez Mde, J., & Gonzalez-Vazquez, T. (2003). A model for integrating mental health care resources in the rural population of Mexico. Salud Publica de Mexico, 45(1), 19–26.PubMedCrossRefGoogle Scholar
  64. Singh, S. P., Brown, L., Winsper, C., Gajwani, R., Islam, Z., Jasani, R., … Birchwood, M. (2015). Ethnicity and pathways to care during first episode psychosis: The role of cultural illness attributions. BMC Psychiatry, 15, 287.PubMedPubMedCentralCrossRefGoogle Scholar
  65. Smith, M. J., Cloninger, C. R., Harms, M. P., & Csernansky, J. G. (2008). Temperament and character as schizophrenia-related endophenotypes in non-psychotic siblings. Schizophrenia Research, 104(1–3), 198–205.PubMedPubMedCentralCrossRefGoogle Scholar
  66. Solis-Vivanco, R., Mondragon-Maya, A., Leon-Ortiz, P., Rodriguez-Agudelo, Y., Cadenhead, K. S., & de la Fuente-Sandoval, C. (2014). Mismatch negativity reduction in the left cortical regions in first-episode psychosis and in individuals at ultra high-risk for psychosis. Schizophrenia Research, 158(1–3), 58–63.PubMedCrossRefGoogle Scholar
  67. Sparks, A., McDonald, S., Lino, B., O’Donnell, M., & Green, M. J. (2010). Social cognition, empathy and functional outcome in schizophrenia. Schizophrenia Research, 122(1–3), 172–178.PubMedCrossRefGoogle Scholar
  68. Steadman, H. J., Mulvey, E. P., Monahan, J., Robbins, P. C., Appelbaum, P. S., Grisso, T., … Silver, E. (1998). Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Archives of General Psychiatry, 55(5), 393–401.PubMedCrossRefGoogle Scholar
  69. Stevens, M. C., Calhoun, V. D., & Kiehl, K. A. (2005). Hemispheric differences in hemodynamics elicited by auditory oddball stimuli. NeuroImage, 26(3), 782–792.PubMedPubMedCentralCrossRefGoogle Scholar
  70. Van Dorn, R. A., Swanson, J. W., Elbogen, E. B., & Swartz, M. S. (2005). A comparison of stigmatizing attitudes toward persons with schizophrenia in four stakeholder groups: Perceived likelihood of violence and desire for social distance. Psychiatry, 68(2), 152–163.PubMedCrossRefGoogle Scholar
  71. Vargas-Huicochea, I., Huicochea, L., Berlanga, C., & Fresan, A. (2014). Taking or not taking medications: Psychiatric treatment perceptions in patients diagnosed with bipolar disorder. Journal of Clinical Pharmacology Therapeutics, 39(6), 673–679.CrossRefGoogle Scholar
  72. Vargas-Huicochea, I., Muggenburg, M. E., Palacios, J., & Heinze, G. (2012). Preferencias de especialidad médica entre los estudiantes de pregrado de la Facultad de Medicina de la UNAM: ¿En qué lugar se ubica la Psiquiatría? Salud Mental, 35(6), 465–473.Google Scholar
  73. WHO. (2014). Health system financing country profile: Mexico, 2014. 2016, from
  74. Yang, L. H., Kleinman, A., Link, B. G., Phelan, J. C., Lee, S., & Good, B. (2007). Culture and stigma: Adding moral experience to stigma theory. Social Science & Medicine, 64(7), 1524–1535.CrossRefGoogle Scholar
  75. Yudofsky, S. C., Silver, J. M., Jackson, W., Endicott, J., & Williams, D. (1986). The overt aggression scale for the objective rating of verbal and physical aggression. American Journal of Psychiatry, 143(1), 35–39.PubMedCrossRefGoogle Scholar
  76. Yung, A. R., & McGorry, P. D. (1996). The prodromal phase of first-episode psychosis: Past and current conceptualizations. Schizophrenia Bulletin, 22(2), 353–370.PubMedCrossRefGoogle Scholar
  77. Yung, A. R., McGorry, P. D., Francey, S. M., Nelson, B., Baker, K., Phillips, L. J., … Amminger, G. P. (2007). PACE: A specialised service for young people at risk of psychotic disorders. The Medical Journal of Australia, 187(7 Suppl), S43–S46.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Francisco Reyes-Madrigal
    • 1
  • Pablo León-Ortiz
    • 2
  • Camilo de la Fuente-Sandoval
    • 3
    Email author
  1. 1.Laboratory of Experimental PsychiatryInstituto Nacional de Neurología y NeurocirugíaMexico CityMexico
  2. 2.Laboratory of Experimental Psychiatry & Department of EducationInstituto Nacional de Neurología y NeurocirugíaMexico CityMexico
  3. 3.Laboratory of Experimental Psychiatry & Neuropsychiatry DepartmentInstituto Nacional de Neurología y NeurocirugíaMexico CityMexico

Personalised recommendations